1st Oct 2008 17:23
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 30 September 2008, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares at a price of £12.07 per share and ADSs at a price of $43.49 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2008 to 30 September 2008:
|
Non Executive Director |
Ordinary Shares |
American Depository Shares (ADSs) |
|
Sir Christopher Gent |
2,796.19 |
|
|
Prof. Sir Roy Anderson |
543.70 |
|
|
Dr Stephanie Burns |
601.11 |
|
|
Mr Lawrence Culp |
1,202.22 |
|
|
Sir Crispin Davis |
1,553.44 |
|
|
Sir Deryck Maughan |
1,202.22 |
|
|
Dr Daniel Podolsky |
772.86 |
|
|
Sir Ian Prosser |
1,087.41 |
|
|
Dr Ronaldo Schmitz |
621.38 |
|
|
Mr Tom de Swaan |
543.70 |
|
|
Sir Robert Wilson |
491.92 |
The Company and the Non-Executive Directors were informed of these allocations on 1 October 2008.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
1 October 2008
Related Shares:
Glaxosmithkline